Phase I and pharmacokinetic study of intraperitoneal topotecan (Q46043090)

From Wikidata

Jump to navigation Jump to search

scientific article published in January 1998

edit

Language	Label	Description	Also known as
English	Phase I and pharmacokinetic study of intraperitoneal topotecan	scientific article published in January 1998

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9848578

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/9848578

title

Phase I and pharmacokinetic study of intraperitoneal topotecan (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9848578

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/9848578

main subject

pharmacokinetics

1 reference

based on heuristic

inferred from title

author

Patricia S. Braly

series ordinal

4

object named as

Braly PS

0 references

author name string

Plaxe SC

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9848578

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/9848578

Christen RD

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9848578

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/9848578

O'Quigley J

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9848578

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/9848578

Freddo JL

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9848578

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/9848578

McClay E

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9848578

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/9848578

Heath D

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9848578

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/9848578

Howell SB

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9848578

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/9848578

publication date

1 January 1998

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9848578

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/9848578

published in

Investigational New Drugs

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9848578

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/9848578

volume

16

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9848578

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/9848578

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9848578

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/9848578

page(s)

147-153

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9848578

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/9848578

cites work

Phase I trial and pharmacologic trial of sequences of paclitaxel and topotecan in previously treated ovarian epithelial malignancies: a Gynecologic Oncology Group study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9848578

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9848578

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimating the probability of toxicity at the recommended dose following a phase I clinical trial in cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9848578

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacokinetics of topotecan

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9848578

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9848578

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-performance liquid chromatographic analysis of the new antitumour drug SK&F 104864-A (NSC 609699) in plasma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9848578

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9848578

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination intraperitoneal chemotherapy with cisplatin, cytarabine, and doxorubicin for refractory ovarian carcinoma and other malignancies principally confined to the peritoneal cavity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9848578

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methods for dose finding studies in cancer clinical trials: a review and results of a Monte Carlo study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9848578

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical and pharmacokinetic study of topotecan administered by a 24-hour continuous infusion

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9848578

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topotecan in Platinum- and Paclitaxel-Resistant Ovarian Cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9848578

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacology of Intraperitoneal Chemotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9848578

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Continual reassessment method: a practical design for phase 1 clinical trials in cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9848578

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9848578

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9848578

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1023/A:1006045125018

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9848578

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/9848578

Dimensions Publication ID

1024847601

0 references

PubMed publication ID

9848578

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9848578

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/9848578

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46043090&oldid=2213283895"